T cell-depleted hla-haploidentical stem cell transplantation: In thalassemia young patients

Pediatric Reports

Volumn 3, Issue 2S, 2011, Pages 34-37

  Sodani, Pietro ^a   Isgrò, Antonella ^a   Gaziev, Javid ^a   Paciaroni, Katia ^a   Marziali, Marco ^a   Simone, Maria Domenica ^a   Roveda, Andrea ^a   Alfieri, Cecilia ^a   De Angelis, Gioa ^a   Gallucci, Cristiano ^a   Fabio, Torelli ^a   Isacchi, Giancarlo ^b   Zinno, Francesco ^b   Landi, Fabiola ^b   Adorno, Gaspare ^a   Lanti, Alessandro ^a   Testi, Manuela ^c   Andreani, Marco ^c   Lucarelli, Guido ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Immunohematology and Transfusion Medicine Service Policlinico Tor Vergata ^*

Author keywords

Stem cell transplantation; Thalassemia

Indexed keywords

EID: 84891493893     PISSN: None     EISSN: 20367503     Source Type: Journal    
DOI: 10.4081/pr.2011.s2.e13     Document Type: Article

References (17)

1. Lucarelli G, Clift R, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996;87:2082-8.
2. Lucarelli G, Galimberti M, Giardini C, et al. Bone marrow transplantation in tha-lassemia. Ann N Y Acad Sci 1998;850: 270-5.
3. La Nasa G, Argiolu F, Giardini C, et al. Un-related bone marrow transplantation for beta-thalassemia patients: the experience of the Italian Bone Marrow Transplant group. Ann N Y Acad Sci 2005;1054:81-85.
4. Aversa F, Tabilio A, Terenzi A, et al. Suc-cessful engraftment of T-cell depleted haploidentical "three-loci" incompat-ible transplants in leukemia patients by addition of recombinant human granu-locyte colony-stimulating factor-mobi- lized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84:3948-55.
5. Polchi P, Lucarelli G, et al. Haploidentical bone marrow transplantation from mother to child with advanced leukemia. Bone Marrow Transplant 1995;16:529-35.
6. Sodani P, Polchi P, Erer B, et al. Haploiden-tical T depleted peripheral blood and stem cells plus bone marrow transplantation from mother to child with thalassemia dis-ease. Hematol J 2003;4:206.
7. Sodani P, Polchi P, Erer B. et al. Haploiden-tical T depleted peripheral blood and stem cells plus bone marrow transplantation from mother to child with thalassemia dis-ease. Haematologica, 2003:88.
8. Sodani P, Gaziev D, Polchi P, et al. A new approach for bone marrow transplantation in class 3 thalassemic patients aged less than 17 years. Blood 2004;104:1201-3.
9. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993;329:840-4.
10. Lazarus HM, Koc ON, Devine SM, et al. Co-transplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hemato-logic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-8.
11. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic ef-fects of bone marrow-derived mes-enchymal cells in children with osteogen-esis imperfecta. Nat Med 1999;5:309-13.
12. Ball LM, Bernardo ME, Roelofs H, et al. Co-transplantation of ex vivo expanded mes-enchymal stem cells accelerates lympho-cyte recovery and may reduce the risk of graft failure in haploidentical hematopoi-etic stem cell transplantation. Blood 2007;110:2764-77.
13. Sodani P, Isgrò A, Gaziev J, et al. Purified T-depleted, CD341 peripheral blood and bone marrow cell transplantation from haploidentical mother to child with tha-lassemia. Blood 2010;115:1296-302.
14. Isgrò A, Marziali M, Sodani P, et al. Im-munohematologic Reconstitution in Pedi-atric Patients after T Cell-Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia. Biol Blood Marrow Trans-plant 2010;16:1557-66.
15. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen presenting cells. Science 1999;285:412-5.
16. Della Chiesa M, Vitale M, Carlomagno S, et al. The natural killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer IG-like receptors. Eur J Immunol 2003;33:1657-66.
17. Aversa F, Terenzi A, Tabilio A, et al. Full hap-lotype mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005;23:3447-54.